Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SNTA > SEC Filings for SNTA > Form 8-K on 1-Apr-2013All Recent SEC Filings

Show all filings for SYNTA PHARMACEUTICALS CORP | Request a Trial to NEW EDGAR Online Pro



Entry into a Material Definitive Agreement, Creation of a Direct Finan

ITEM 1.01 Entry into a Material Definitive Agreement.

On September 30, 2010, Synta Pharmaceuticals Corp. (the "Company") and its wholly owned subsidiary, Synta Securities Corp. ("Synta Securities"), as guarantor, entered into a Loan and Security Agreement (as amended, the "Loan Agreement") with General Electric Capital Corporation ("GECC"), in its capacity as agent ("Agent") for GECC and MidCap Funding III, LLC ("MidCap") as lenders (the "Lenders"), pursuant to which the Company borrowed an aggregate of $15,000,000, the outstanding principal balance of which was $9,600,000 as of March 28, 2013 (the "Initial Term Loan").

On March 28, 2013 (the "Closing Date"), the Company, Synta Securities and the Lenders entered into the Eighth Amendment to the Loan Agreement (the "Amendment"), pursuant to which the Lenders have made an additional term loan of $12,900,000 to the Company (the "Additional Term Loan" and together with the Initial Term Loan, the "Loan"), bringing the total outstanding principal amount of the Loan to $22,500,000. No additional advances are available under the Loan Agreement. Pursuant to the Amendment, the Loan will accrue interest in arrears from the Closing Date until it is fully repaid at a fixed annual interest rate equal to 9.75%. The Company must make monthly interest payments commencing on April 1, 2013 and must repay principal on the Loan in thirty (30) equal consecutive monthly installments commencing on January 1, 2014. In addition, upon repayment in full of the Loan, the Company is obligated to make a final payment fee equal to 3.5% of the original principal amount of the Loan. The Company may prepay the full amount of the Loan subject to a prepayment premium of 1% in year three, 2% in year two, and 4% in year one of the prepayment amount, which premium will not apply under certain prepayment circumstances.

Except as otherwise set forth in the Amendment, all terms and conditions of the Loan Agreement remain in full force and effect.

The above description of the Amendment is only a summary and is qualified in its entirety by reference to the full text of the Amendment, which is filed as exhibit 10.1.1 hereto and is incorporated by reference herein.

ITEM 2.03 Creation of a Direct Financial Obligation or an
Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                                Description

10.1.1        Eighth Amendment to Loan and Security Agreement dated as of March 28,
              2013 by and among the Company, Synta Securities Corp., General
              Electric Capital Corporation, and MidCap Funding III, LLC.

10.1.2        Amended and Restated Promissory Note issued by the Registrant to
              General Electric Capital Corporation.

10.1.3        Amended and Restated Promissory Note issued by the Registrant to
              MidCap Funding III, LLC.

  Add SNTA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SNTA - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.